Onyx Biotec IPO
Onyx Biotec is an NSE SME IPO listed on the NSE SME platform, priced at ₹58–₹61 per share. The stock debuted at ₹54.05. The IPO had a lot size of ₹2000 shares and a minimum investment of ₹1,22,000.
Onyx Biotec Limited IPO
- IPO Dates
- Nov 13, 2024 – Nov 18, 2024
- Price band
- ₹58-61 per equity share
- Minimum Investment
- ₹1,22,000
- Issue size
- ₹29.34 Cr
- Lot size
- 2000
- Allotment Date
- Nov 19, 2024
- Listing
- Nov 22, 2024
- Listing At
- NSE SME
IPO timeline
-
Nov 13, 2024
Open Date
Completed
-
Nov 18, 2024
Close Date
Completed
-
Nov 19, 2024
Allotment Date
Completed
-
Nov 22, 2024
Listing Date
Completed
Onyx Biotec IPO Essentials
Onyx Biotec IPO Details
Onyx Biotec IPO is priced at ₹58-61 per share with a total issue size of 29.34 crore. The IPO has a lot size of 2000 shares and is listed on NSE SME.
- Issue price
- ₹58-61 per equity share
- Lot size
- 2000 shares
- Face value
- ₹10 Per Equity Share
- Issue size
- 4,810,000 shares(aggregating up to ₹29.34 Cr)
- Total issue size
- 48,10,000 shares
(aggregating up to ₹29.34 crore) - Fresh issue
- 48,10,000 shares
(aggregating up to ₹29.34 crore) - Listing at
- NSE SME
- List price
- 54.05
- Listing date
- Registrar
- Mas Services Limited
- Lead manager
-
Horizon Management Private Limited
Market Lot Size
Investors can bid for a minimum of 2000 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 2000 | ₹1,22,000 |
| Retail(max) | 1 | 2000 | ₹1,22,000 |
| NII (min) | 2 | 4000 | ₹2,44,000 |
Onyx Biotec IPO Reservation
Onyx Biotec IPO reservation details show category-wise allocation of shares. Out of the total 48,10,000 shares, approximately 18.96% are reserved for QIB, 14.3% for NII, 33.26% for retail investors, 5.07% for market maker, and 28.4% for anchor investors.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | 13,66,000 (28.4%) | |
| Market Maker Shares Offered | 2,44,000 (5.07%) | |
| QIB Shares Offered | 9,12,000 (18.96%) | |
| NII (HNI) Shares Offered | 6,88,000 (14.3%) | |
| Retail Shares Offered | 16,00,000 (33.26%) | |
| Total Shares Offered | 48,10,000 (100%) |
Onyx Biotec IPO Analytics
Onyx Biotec IPO category-wise subscription trends show day-wise participation across QIB, NII, and retail investors.
Onyx Biotec IPO Subscription Status
Onyx Biotec IPO subscription status shows demand across retail, NII, and QIB categories, helping investors understand overall participation trends.
The IPO subscription status indicates investor demand across categories.
| As on | QIB / NII | Retail | Total |
|---|---|---|---|
| Shares Offered / Reserved | 912,000 / 688,000 | 1,600,000 | 3,200,000 |
|
Day 1
13-11-24 06:00 PM
|
(0.00 / 1.70) x | 5.57 x | 3.15 x |
|
Day 2
14-11-24 06:00 PM
|
(0.00 / 8.15) x | 16.40 x | 9.95 x |
|
Day 3
18-11-24 06:00 PM
|
(32.49 / 603.44) x | 119.36 x | 198.68 x |
Onyx Biotec Valuations
Earnings
- EPS Pre IPO
- ₹2.28/-
- EPS Post IPO
- ₹4.33/-
- P/E Pre IPO
- 26.81
- P/E Post IPO
- 14.1
Returns
- ROE
- 4.99%
- ROCE
- 3.71%
- RoNW
- 4.99%
- PAT Margin
- 12.42
Fundamentals
- Debt / Equity
- 1.21
- Price / Book
- 3.10
Onyx Biotec Financials( In Lakhs)
| 31-Mar-24 | 31-Mar-23 | 31-Mar-22 | |
|---|---|---|---|
| Assets | 7,413.58 | 5,872.36 | 3,683.84 |
| Revenue | 5,387.43 | 3,961.65 | 4,498.09 |
| Profit After Tax | 303.16 | 184.46 | 335.29 |
| Net Worth | 2,487.87 | 1,820.16 | 1,637.59 |
| Reserves & Surplus | 1,155.65 | 1,230.00 | 1,047.43 |
| Total Borrowing | 3,078.04 | 2,922.83 | 1,224.39 |
Onyx Biotec Company & Offer Insights
About Onyx Biotec
Incorporated in the month of May 2005, Onyx Biotec Limited is engaged in the field of pharmaceutical industry with sterile water for injections. The company, currently manufacturing Sterile Water for Injections is also a leading pharmaceutical contract manufacturer providing a holistic portfolio of Dry Powder Injections and Dry Syrups, both to domestic as well as international markets.
The company has two manufacturing units in Solan, Himachal Pradesh. Unit I has the daily production capacity of 638,889 units of Sterile Water for Injections and Unit II makes 40,000 units of dry powder injections and 26,667 units of dry syrup per day in a single shift.
Hetero Healthcare Limited, Mankind Pharma Limited, Sun Pharmaceutical Industries Limited, Aristo Pharmaceuticals Private Limited, Macleods Pharmaceuticals Limited, Mapra Laboratories Private Limited, Axa Parenterals Limited, FDC Limited, Zuventus Healthcare Limited, Akums Drugs and Pharmaceuticals Limited, Reliance Life Sciences Limited, among others are some of the clients for the company.
At the end of May 31, 2024, it had a clientele of over 100 Indian and multinational pharmaceutical companies.
ROHS Certification Private Limited has issued certificates for the management system, ISO 9001:2015 and ISO 14001:2015.
The company, as of July 31, 2024, employs 175 staff across the different departments.
Onyx Biotec Promoter(s)
Sanjay Jain, Naresh Kumar, Fateh Pal Singh are the company's promoters of Onyx Biotec.
Onyx Biotec IPO Issue Objectives
- •
- Upgradation of existing manufacturing Unit I to manufacture large volume parentals for intravenous use
- •
- Setting up a high-speed cartooning packaging line at existing manufacturing Unit II for Dry Powder Injections
- •
- Prepayment or repayment of all or a portion of certain loans availed by the Company
- •
- General Corporate Purposes.
Onyx Biotec IPO - Peers Comparison
| Company Name | EPS (Basic) | EPS (Diluted) | NAV (per share) (Rs) | P/E (x) | RoNW (%) | P/BV Ratio | Financial statements |
|---|---|---|---|---|---|---|---|
| Onyx Biotec Limited | 2.28 | 2.28 | 18.67 | 26.81 | 12.19 | 3.27 | Standalone |
| Suven Pharmaceuticals Limited | 11.8 | 11.8 | 375.82 | 83.92 | 14.64 | 2.64 | Consolidated |
| JB Chemicals | 35.66 | 35.66 | 188.37 | 53.63 | 18.9 | 10.15 | Consolidated |
Notes:
- Return on Net Worth (%) = Profit for the year ended March 31, 2023 divided by Total Equity of the Company as on March 31, 2024.
- NAV is computed as the company's Total Equity as of March 31, 2023, divided by the outstanding number of equity shares as of March 31, 2024.
Contact Information
Contact Details
Onyx Biotec
+91 172 265 6384
Bir Plassi Near Sainimajraropar, Nalagarh Road, District Solan – 174101
Registrar Contact Details
Frequently Asked Questions
Click any question to reveal the answer
Onyx Biotec IPO is a book-built IPO worth ₹29.34 crore. The price band is ₹58–₹61 per share. The IPO opens on Nov 13, 2024 and closes on Nov 18, 2024. It will be listed on NSE SME Platform. Mas Services Limited is the registrar.
The price band of Onyx Biotec IPO is ₹58 to ₹61 per share.
The lot size of Onyx Biotec IPO is 2000 shares.
The minimum investment for Onyx Biotec IPO is approximately ₹1,22,000 based on the upper price band .
Onyx Biotec IPO opens on Nov 13, 2024 and closes on Nov 18, 2024.
The allotment date of Onyx Biotec IPO is Nov 19, 2024.
Onyx Biotec IPO is expected to be listed on Nov 22, 2024, on NSE SME Platform.
Onyx Biotec IPO valuation snapshot: P/E 14.1, EPS ₹4.33/-, P/B 3.10, RoNW 4.99%, and market cap N/A.
To apply for Onyx Biotec IPO, open the IPO Ji app or website, select the IPO, choose your demat account, enter the quantity, and submit the application.
You can check the live subscription status of Onyx Biotec IPO on IPO Ji or stock exchange websites. It shows real-time demand across retail, NII, and QIB categories.
Pre-apply allows investors to submit their IPO application before the bidding period starts. The order is placed automatically when the IPO opens.
If you pre-apply for Onyx Biotec IPO, your order will be placed when the IPO bidding starts, and a UPI mandate request will be generated.
You can check Onyx Biotec IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Onyx Biotec IPO allotment status on IPO Ji for quick and easy access.